RNA Interference for Varroa Mite Viral Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for controlling Varroa mite infestations in honeybee colonies are ineffective due to mite resistance and the introduction of toxic chemicals into honey intended for human consumption, posing a threat to bee health and colony survival.

Innovation Solution

The use of RNA interference technology to reduce viral load and suppress viral replication in Varroa mites and honeybees by administering a composition comprising a trigger polynucleotide with a nucleic acid sequence identical or complementary to bee viral genes, specifically targeting viruses such as DWV and IAPV, thereby downregulating viral gene expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical miticides are used to control Varroa mite infestations, then mite population is reduced, but toxic chemicals are introduced into honey and mite resistance develops

Engineering Contradiction:
ImproveVarroa mite control efficacyVSAvoidtoxic chemical residues in honey
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical miticides with RNA interference technology, using double-stranded RNA molecules to specifically target and silence essential mite genes. This biological mechanism substitutes for chemical toxicity, achieving mite population control through gene silencing rather than toxic exposure, thereby eliminating chemical residues in honey while maintaining control efficacy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces double-stranded RNA as an intermediary substance that mediates between the treatment application and the mite population control. The dsRNA acts as a specific mediator that enters mites through feeding, processes through the mite's RNAi pathway, and selectively silences essential genes, providing a targeted control mechanism that avoids non-specific chemical toxicity to the hive environment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If chemical miticides are used to control Varroa mites, then mite population is reduced, but mite resistance to miticides develops

Engineering Contradiction:
ImproveVarroa mite control efficacyVSAvoidmite resistance to miticides
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces chemical miticides with RNA interference technology, using double-stranded RNA molecules to specifically target and silence essential mite genes. This biological mechanism substitutes for chemical toxicity, achieving mite population control through gene silencing rather than toxic exposure, thereby eliminating chemical residues in honey while maintaining control efficacy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameter of control mechanism from chemical toxicity to biological gene silencing. By targeting specific gene sequences through complementary dsRNA binding, the system creates a highly specific control approach that does not rely on toxic thresholds or exposure levels, thereby preventing the development of resistance that occurs with chemical miticides.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If Varroa mites are present in bee colonies, then mite parasitism occurs, but viral load and replication in bees is reduced through RNA interference

Engineering Contradiction:
Improvebee health and viral suppressionVSAvoidviral replication in bees
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces double-stranded RNA as an intermediary substance that mediates between the treatment application and the mite population control. The dsRNA acts as a specific mediator that enters mites through feeding, processes through the mite's RNAi pathway, and selectively silences essential genes, providing a targeted control mechanism that avoids non-specific chemical toxicity to the hive environment.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent extracts and targets specific viral genetic sequences within the mite's genome or associated viruses, using dsRNA complementary to viral gene sequences. This extracts the harmful viral replication function specifically, silencing only the targeted viral genes while leaving other mite and bee functions intact, thereby reducing viral load without affecting overall mite population dynamics or bee health directly.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively reduces viral load and replication in both Varroa mites and honeybees, enhancing their tolerance to diseases and potentially preventing Colony Collapse Disorder, while avoiding the use of toxic chemicals.

Implementation Method 1

The present embodiments relate to compositions and methods for reducing the susceptibility of bees to infectious disease using RNA interference technology

Methodology Applied
Scientific EffectRNA interference:

Implementation Method 2

providing to the Varroa destructor mite or the bee colony a composition comprising an effective amount of at least one trigger polynucleotide comprising a nucleic acid sequence that is essentially identical or essentially complementary to a sequence of at least 21 contiguous nucleotides of a bee viral gene

Methodology Applied
Scientific EffectNucleic acid hybridization:

Data Source

PatentUS10557138B2Compositions and methods for virus control in <i>Varroa </i>mite and bees
Publication Date: 2020.02.11 GREENLIGHT BIOSCIENCES INC
  • US10557138B2 patent drawing
  • US10557138B2 patent drawing
  • US10557138B2 patent drawing

AI summary

Compositions and methods for providing viral control in Varroa mites and bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in Varroa mites and bees by providing trigger polynucleotides targeting viral sequences is disclosed.